NCT06634160View on ClinicalTrials.gov

Assessment of the Prevalence of Steatotic Liver Disease Associated With Metabolic Dysfunction in Patients With Heterozygous Familial Hypercholesterolemia

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

January 30, 2025

Primary Completion Date

January 30, 2027

Study Completion Date

January 30, 2028

Conditions
Heterozygous Familial Hypercholesterolemia
Interventions
DIAGNOSTIC_TEST

Fibroscan

Evaluation of the prevalence of steatosis by measuring ultrasound attenuation with Fibroscan® (non-invasive method, at a distance from a meal (3h fasting)).

OTHER

Sample collection

20 mL whole blood sample

Trial Locations (3)

35033

NOT_YET_RECRUITING

Rennes University Hospital, Rennes

49933

NOT_YET_RECRUITING

CHU angers, Angers

Unknown

RECRUITING

CHU Nantes, Nantes

All Listed Sponsors
collaborator

University Hospital, Angers

OTHER_GOV

collaborator

Rennes University Hospital

OTHER

lead

Nantes University Hospital

OTHER